Selected Grants
A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Clinical TrialPrincipal Investigator · Awarded by Boston Scientific Corporation · 2024 - 2029Duke Lead Extraction Course
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by Philips Image Guided Therapy Corporation · 2024 - 2027Safety and Effectiveness Evaluation of the THERMOCOOL SMARTTOUCH¿ SF Catheter with the TRUPULSE¿ Generator for treatment of drug refractory symptomatic Paroxysmal Atrial Fibrillation (PAF)
Clinical TrialPrincipal Investigator · Awarded by Biosense Webster Inc · 2024 - 2027CRD 1074 FlexPulse - Safety and effectiveness of the TactiFlex SE Catheter and Volt Pulsed Field Ablation (PFA) Generator in subjects with paroxysmal atrial fibrillation
Clinical TrialPrincipal Investigator · Awarded by St. Jude Medical Business Services Inc. · 2024 - 2026Ultra-HFIB
Clinical TrialPrincipal Investigator · Awarded by Icahn School of Medicine at Mount Sinai · 2025 - 2026CHANGE AF
Clinical TrialPrincipal Investigator · Awarded by American Heart Association · 2021 - 2026Neurocognition & Greater Maintenance of Sinus Rhythm in AF (NOGGIN AF)
Clinical TrialCo-Principal Investigator · Awarded by National Institute on Aging · 2021 - 2026Atrial Fibrillation Ablation Program
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by St. Jude Medical Business Services Inc. · 2022 - 2025Postdoctoral Training in Cardiovascular Clinical Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2025Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation
Clinical TrialPrincipal Investigator · Awarded by Boston Scientific Corporation · 2020 - 2025DEFINE-AFIB
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2021 - 2024Philips Corporation Educational Program Agreement-Parent
ConferencePrincipal Investigator · Awarded by Philips Image Guided Therapy Corporation · 2021 - 2024Advanced Mapping Software
Clinical TrialPrincipal Investigator · Awarded by St. Jude Medical Inc. · 2021 - 2023HUMAN USE CONDITION STUDY ASSOCIATION FOR ADVANCEMENT OF MEDICAL INSTRUMENTATION FLUOROSCOPIC EVALUATION OF 3D CURVATURE OF IMPLANTED LEADS IN HUMANS
Clinical TrialPrincipal Investigator · Awarded by Biotronik, Inc. · 2020 - 2022Impact of Apple Watch on Quality of Life in Patients with Atrial Fibrillation
ResearchCo Investigator · Awarded by Yale University · 2021 - 2022ORBIT AF
ResearchPrincipal Investigator · Awarded by University of British Columbia · 2020 - 2022Accelerometer Sensing for Micra AV
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2020 - 2022MAESTRO-PAF for Major Adverse Events and Stroke in Paroxysmal Atrial Fibrillation
ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2016 - 2022Impact of AF Burden on Cardiovascular Events
ResearchPrincipal Investigator · Awarded by St. Jude Medical Inc. · 2019 - 2021MILES Study
Clinical TrialPrincipal Investigator · Awarded by Philips Healthcare · 2019 - 2021Multiple Cardiac Sensors for Management of Heart Failure
Clinical TrialPrincipal Investigator · Awarded by Boston Scientific Corporation · 2018 - 2021Micra Atrial Tracking Using A Ventricular Accelerometer 2
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2019 - 2020Spectranetics/duke Educational Program
ConferencePrincipal Investigator · Awarded by Spectranetics · 2018 - 2019Get With The Guidelines AHA Measure Reliability Testing SOW #18
ResearchPrincipal Investigator · Awarded by American Heart Association · 2018 - 2019GD-Star -- Atrial Ischemia in AF
ResearchPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2014 - 2019Rates of Stroke Among High Risk Medicare Patients with Atrial Fibrillation and Contraindications to Oral Anticoagulation
ResearchPrincipal Investigator · Awarded by Boston Scientific Corporation · 2017 - 2018Anticoagulation Using the Direct Factor Xa Inhibitor Apixaban During Atrial Fibrillation Catheter Ablation: Prospective, Randomised, Open, Blinded Outcome Comparison to Vitamin K Antagonist Therapy
ResearchPrincipal Investigator · Awarded by Das Kompetenznetz Vorhofflimmern e.V. · 2017 - 2018CAT-HF: Biomarkers Costs
ResearchPrincipal Investigator · Awarded by ResMed Foundation · 2013 - 2017CAT-HF: Arrhythmias Costs
ResearchPrincipal Investigator · Awarded by ResMed Foundation · 2013 - 2017Matching Methods for Comparative Effectiveness Studies of Longitudinal Treatments
ResearchCollaborator · Awarded by Agency for Healthcare Research and Quality · 2015 - 2017MICRA-CAS
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2015 - 2017Extraction Vs Capping Pacing and Defibrillator Leads
ResearchPrincipal Investigator · Awarded by Spectranetics · 2015 - 2016Evaluation of Multielectrode Phased RF Technology in Persistent Atrial Fibrillation
Clinical TrialPrincipal Investigator · Awarded by Medtronic, Inc. · 2014 - 2016A randomized, open-label, active-controlled multi-center study to evaluate the safety of rivaroxaban and vitamin K antagonists in subjects undergoing catheter ablation for atrial fibrillation (VENTURE-AF)
Clinical TrialPrincipal Investigator · Awarded by Janssen Scientific Affairs, LLC. · 2013 - 2015Patterns of Health Care Use, Treatment & Outcomes in Atrial Fibrillation: PATH-AF
ResearchCo Investigator · Awarded by National Institutes of Health · 2010 - 2014Comparative Effectiveness of Therapies for Heart Failure
ResearchCo Investigator · Awarded by Agency for Healthcare Research and Quality · 2010 - 2013External Relationships
- AbbVie, Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Electrophysiology Frontiers
- Element Science
- Kardium
- LivaNova, Inc.
- Medtronic Inc.
- Milestone
- Philips Healthcare
- Sanofi US Services Inc
- Up-to-date
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.